Abivax SA American Depositary Shares (ABVX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Abivax SA American Depositary Shares (ABVX) is down 33.2% since the beginning of the year. At $90 per share, ABVX is trading 39.4% below its 52-week high of $149.

Abivax SA American Depositary Shares (ABVX) has returned -33.15% so far this year and 1,064.73% over the past 12 months.

Based on dividend-adjusted daily data since Oct 20, 2023, ABVX's average daily return is +1.05%, while the average monthly return is +26.96%. At this rate, an investment would double in approximately 0.2 years.

Historically, 61% of months were positive and 39% were negative. The best month was Jul 2025 with a return of +838.2%, while the worst month was Jun 2026 at -32.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ABVX closed higher 49% of trading days. The best single day was Jul 23, 2025 with a return of +586.0%, while the worst single day was Jun 2, 2026 at -44.1%.

Abivax SA American Depositary Shares has an annualized alpha of 856.67%, beta of 1.62, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 23, 2023.

• This stock captured 572.79% of S&P 500 Index gains and 104.49% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ABVX ranks 97 for risk / return — in the top 97% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Abivax SA American Depositary Shares (ABVX) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Abivax SA American Depositary Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Abivax SA American Depositary Shares was 67.46%, occurring on Apr 8, 2025. Recovery took 72 trading sessions.

The current Abivax SA American Depositary Shares drawdown is 37.96%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Abivax SA American Depositary Shares over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Abivax SA American Depositary Shares is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.